Journal of Biological Chemistry · 2009 · 109 citations · 36 references
Veterinary MedicineImmunologyPathobiologyInflammationInnate ImmunitySepsisCytokine BiologyCytokine-mediated PathologyInflammatory SignalingMacrophage BiologySepsis PathophysiologySeptic ShockCellular Inflammatory ResponsesInflammatory Cytokine ProductionMacrophage-mediated InflammationSepsis-associated Cytokine DysregulationSepsis-associated Cytokine ResponseSepsis-associated InflammationSurvival FactorTransgenic Mice
Sepsis is a leading cause of death that is characterized by uncontrolled inflammatory response. In this study, we report that scavenger receptor BI (SR-BI), a high density lipoprotein receptor, is a critical survival factor of sepsis. We induced sepsis using an established septic animal model, cecal ligation and puncture (CLP). CLP induced 100% fatality in SR-BI-null mice but only 21% fatality in wild type littermates. SR-BI-null mice exhibited aberrant inflammatory responses with delayed inflammatory cytokine generation at the early stage of sepsis and highly elevated inflammatory cytokine production 20 h after CLP treatment. To understand the mechanisms underlying SR-BI protection, we elucidated the effect of mac ro phage SR-BI on inflammatory cytokine generation. Macrophages from SR-BI-null mice produced significantly higher levels of inflammatory cytokines than those of wild type controls in response to LPS. Importantly, transgenic mice overexpressing SR-BI were more resistant to CLP-induced septic death. Using an HEK-BlueTM cell system, we demonstrated that expression of SR-BI suppressed TLR4-mediated NF-κB activation. To understand why SR-BI-null mice had a delayed inflammatory response, we elucidated the effect of SR-BI on LPS clearance during sepsis. Compared with wild type controls, SR-BI-null mice had lower plasma LPS levels in the early stage of sepsis and elevated plasma LPS levels 20 h following CLP treatment. In conclusion, our findings demonstrate that SR-BI is a critical protective modulator of sepsis in mice. SR-BI exerts its protective function through its role in modulating inflammatory response in mac ro phages and facilitating LPS recruitment and clearance. Sepsis is a leading cause of death that is characterized by uncontrolled inflammatory response. In this study, we report that scavenger receptor BI (SR-BI), a high density lipoprotein receptor, is a critical survival factor of sepsis. We induced sepsis using an established septic animal model, cecal ligation and puncture (CLP). CLP induced 100% fatality in SR-BI-null mice but only 21% fatality in wild type littermates. SR-BI-null mice exhibited aberrant inflammatory responses with delayed inflammatory cytokine generation at the early stage of sepsis and highly elevated inflammatory cytokine production 20 h after CLP treatment. To understand the mechanisms underlying SR-BI protection, we elucidated the effect of mac ro phage SR-BI on inflammatory cytokine generation. Macrophages from SR-BI-null mice produced significantly higher levels of inflammatory cytokines than those of wild type controls in response to LPS. Importantly, transgenic mice overexpressing SR-BI were more resistant to CLP-induced septic death. Using an HEK-BlueTM cell system, we demonstrated that expression of SR-BI suppressed TLR4-mediated NF-κB activation. To understand why SR-BI-null mice had a delayed inflammatory response, we elucidated the effect of SR-BI on LPS clearance during sepsis. Compared with wild type controls, SR-BI-null mice had lower plasma LPS levels in the early stage of sepsis and elevated plasma LPS levels 20 h following CLP treatment. In conclusion, our findings demonstrate that SR-BI is a critical protective modulator of sepsis in mice. SR-BI exerts its protective function through its role in modulating inflammatory response in mac ro phages and facilitating LPS recruitment and clearance. Sepsis is one of the major causes of death that claims over 215,000 lives and costs $16.7 billion per year in America alone (1Bone R.C. Ann. Intern. Med. 1991; 115: 457-469Crossref PubMed Scopus (1238) Google Scholar, 2Angus D.C. Linde-Zwirble W.T. Lidicker J. Clermont G. Carcillo J. Pinsky M.R. Crit. Care Med. 2001; 29: 1303-1310Crossref PubMed Scopus (6735) Google Scholar, 3Martin G.S. Mannino D.M. Eaton S. Moss M. N. Engl. J. Med. 2003; 348: 1546-1554Crossref PubMed Scopus (4871) Google Scholar, 4Riedemann N.C. Guo R.F. Ward P.A. J. Clin. Investig. 2003; 112: 460-467Crossref PubMed Scopus (564) Google Scholar). The death rate from sepsis is high, exceeding 50%, due to poor understanding of the disease (5Sessler C.N. Perry J.C. Varney K.L. Curr. Opin. Crit. Care. 2004; 10: 354-363Crossref PubMed Scopus (35) Google Scholar). Identifying molecules involved in sepsis, especially endogenous protective modulators, is of great importance not only in understanding the mechanisms but also in providing new insights for efficient therapies. Scavenger receptor BI (SR-BI 2The abbreviations used are: SR-BIscavenger receptor BIHDLhigh density lipoproteinILinterleukinTNF-αtumor necrosis factor-αCLPcecal ligation and punctureELISAenzyme-linked immunosorbent assayLPSlipopolysaccharide. or Scarb1) is a 75-kDa membrane protein expressed in the liver, endothelial cells, macrophages, and steroidogenic tissues (6Krieger M. J. Clin. Investig. 2001; 108: 793-797Crossref PubMed Scopus (335) Google Scholar, 7Chinetti G. Gbaguidi F.G. Griglio S. Mallat Z. Antonucci M. Poulain P. Chapman J. Fruchart J.C. Tedgui A. Najib-Fruchart J. Staels B. Circulation. 2000; 101: 2411-2417Crossref PubMed Scopus (390) Google Scholar). It is a well established high density lipoprotein (HDL) receptor. It mediates intracellular uptake of cholesterol ester from HDL, which plays a key role in regulating plasma cholesterol levels and steroidogenesis (8Acton S. Rigotti A. Landschulz K.T. Xu S. Hobbs H.H. Krieger M. Science. 1996; 271: 518-520Crossref PubMed Scopus (2011) Google Scholar, 9Kozarsky K.F. Donahee M.H. Rigotti A. Iqbal S.N. Edelman E.R. Krieger M. Nature. 1997; 387: 414-417Crossref PubMed Scopus (631) Google Scholar, 10Rigotti A. Trigatti B.L. Penman M. Rayburn H. Herz J. Krieger M. Proc. Natl. Acad. Sci. U.S.A. 1997; 94: 12610-12615Crossref PubMed Scopus (761) Google Scholar, 11Kraemer F.B. Mol. Cell. Endocrinol. 2007; 265–266: 42-45Crossref PubMed Scopus (124) Google Scholar). Mice deficient in SR-BI have a 2-fold increase in plasma cholesterol levels and develop cardiovascular diseases (10Rigotti A. Trigatti B.L. Penman M. Rayburn H. Herz J. Krieger M. Proc. Natl. Acad. Sci. U.S.A. 1997; 94: 12610-12615Crossref PubMed Scopus (761) Google Scholar, 12Arai T. Wang N. Bezouevski M. Welch C. Tall A.R. J. Biol. Chem. 1999; 274: 2366-2371Abstract Full Text Full Text PDF PubMed Scopus (284) Google Scholar, 13Braun A. Trigatti B.L. Post M.J. Sato K. Simons M. Edelberg J.M. Rosenberg R.D. Schrenzel M. Krieger M. Circ. Res. 2002; 90: 270-276Crossref PubMed Scopus (429) Google Scholar, 14Kozarsky K.F. Donahee M.H. Glick J.M. Krieger M. Rader D.J. Arterioscler. Thromb. Vasc. Biol. 2000; 20: 721-727Crossref PubMed Scopus (307) Google Scholar, 15Yu H. Zhang W. Yancey P.G. Koury M.J. Zhang Y. Fazio S. Linton M.F. Arterioscler. Thromb. Vasc. Biol. 2006; 26: 150-156Crossref PubMed Scopus (35) Google Scholar, 16Van Eck M. Twisk J. Hoekstra M. Van Rij B.T. Van Der Lans C.A. Bos I.S. Kruijt J.K. Kuipers F. Van Berkel T.J. J. Biol. Chem. 2003; 278: 23699-23705Abstract Full Text Full Text PDF PubMed Scopus (194) Google Scholar). Recent studies reveal that SR-BI is a multifunctional protein. It activates endothelial nitric-oxide synthase in endothelial cells in the presence of HDL (17Li X.A. Titlow W.B. Jackson B.A. Giltiay N. Nikolova-Karakashian M. Uittenbogaard A. Smart E.J. J. Biol. Chem. 2002; 277: 11058-11063Abstract Full Text Full Text PDF PubMed Scopus (151) Google Scholar, 18Yuhanna I.S. Zhu Y. Cox B.E. Hahner L.D. Osborne-Lawrence S. Lu P. Marcel Y.L. Anderson R.G. Mendelsohn M.E. Hobbs H.H. Shaul P.W. Nat. Med. 2001; 7: 853-857Crossref PubMed Scopus (649) Google Scholar, 19Mineo C. Yuhanna I.S. Quon M.J. Shaul P.W. J. Biol. Chem. 2003; 278: 9142-9149Abstract Full Text Full Text PDF PubMed Scopus (331) Google Scholar, 20Gong M. Wilson M. Kelly T. Su W. Dressman J. Kincer J. Matveev S.V. Guo L. Guerin T. Li X.A. Zhu W. Uittenbogaard A. Smart E.J. J. Clin. Investig. 2003; 111: 1579-1587Crossref PubMed Scopus (136) Google Scholar), induces apoptosis in the absence of HDL/endothelial nitric-oxide synthase (21Li X.A. Guo L. Dressman J.L. Asmis R. Smart E.J. J. Biol. Chem. 2005; 280: 19087-19096Abstract Full Text Full Text PDF PubMed Scopus (59) Google Scholar), and protects against nitric oxide (NO)-induced oxidative damage (22Li X.A. Guo L. Asmis R. Nikolova-Karakashian M. Smart E.J. Circ. Res. 2006; 98: e60-65Crossref PubMed Scopus (24) Google Scholar). Emerging evidence indicates that specific expression of SR-BI in macrophages provides protection against the development of atherosclerosis, and importantly, it seems that SR-BI exerts this protection independently of its role in regulating lipoprotein metabolism or cholesterol efflux (23Covey S.D. Krieger M. Wang W. Penman M. Trigatti B.L. Arterioscler. Thromb. Vasc. Biol. 2003; 23: 1589-1594Crossref PubMed Scopus (195) Google Scholar, 24Zhang W. Yancey P.G. Su Y.R. Babaev V.R. Zhang Y. Fazio S. Linton M.F. Circulation. 2003; 108: 2258-2263Crossref PubMed Scopus (174) Google Scholar, 25Van Eck M. Bos I.S. Hildebrand R.B. Van Rij B.T. Van Berkel T.J. Am. J. Pathol. 2004; 165: 785-794Abstract Full Text Full Text PDF PubMed Scopus (149) Google Scholar). The mechanisms underlying the protection of macrophage SR-BI against atherosclerosis are unclear. scavenger receptor BI high density lipoprotein interleukin tumor necrosis factor-α cecal ligation and puncture enzyme-linked immunosorbent assay lipopolysaccharide. We recently reported that SR-BI protects against endotoxin-induced animal death through suppression of NO-induced cytotoxicity (22Li X.A. Guo L. Asmis R. Nikolova-Karakashian M. Smart E.J. Circ. Res. 2006; 98: e60-65Crossref PubMed Scopus (24) Google Scholar). A by L. A. J. Clin. Investig. PubMed Scopus Google the protective role of SR-BI in animal and the demonstrated that to its protective studies that SR-BI a role in sepsis. using in cell R. Z. M. F. A. G. Proc. Natl. Acad. Sci. U.S.A. 2006; PubMed Scopus Google reported recently that SR-BI the uptake of which a that this uptake and a role in sepsis. the of animal G. C. J. Google Scholar), it is of importance to and SR-BI plays a protective role in sepsis. In this study, we the role of SR-BI in sepsis using an established septic animal model, cecal ligation and puncture (CLP). We demonstrated that SR-BI is a critical survival factor of sepsis in mice. In to protection against animal death by not protection against CLP-induced septic animal that SR-BI than regulating production in sepsis. Using a transgenic animal model, macrophages, and cell system, we demonstrated that SR-BI inflammatory response in macrophages which to protection against septic death. by using a from the of LPS from from factor from from from immunosorbent assay for tumor necrosis factor-α and were from for or and were from for LPS from mice on were from Jackson and were by mice. used for The were with a and were by the Care and of the of SR-BI and a (21Li X.A. Guo L. Dressman J.L. Asmis R. Smart E.J. J. Biol. Chem. 2005; 280: 19087-19096Abstract Full Text Full Text PDF PubMed Scopus (59) Google Scholar). The transgenic mice in a were by the of mice were by using The transgenic mice were to SR-BI-null mice to transgenic and in an SR-BI-null The were with to CLP by J. A. 2005; PubMed Scopus Google Scholar). to mice were by of in 100% using A the The with a and to a of cecal The to the and the and were with The mice were with were of the for a to mice were by and 20 h following The by puncture or and at The levels were with the system, which used to the of the levels were with a which used to the generation of in and the or LPS levels were with to to SR-BI-null mice following the by L. A. J. Clin. Investig. PubMed Scopus Google Scholar). the CLP and survival for a macrophages were B. S. C. S.V. Post J. 2003; PubMed Scopus Google Scholar). cells were in a at in and of macrophage factor for The of the cells were in for h and with LPS at and for and 20 h in and cytokines in the were with the cells, which and a NF-κB were from The cells were with wild type SR-BI or and or were by cells or were in a in and to and with LPS at and for of the with and at for LPS activates in of NF-κB which the to The by at by with protein with a The at a rate of in and of with of assay to the cholesterol of and with and of the on a a at the of to the of in the following the by B. M. 1997; PubMed Scopus (24) Google Scholar). from of using a with using a of The survival assay by a using in by in more than by of by using were at We a well established CLP sepsis to SR-BI is for protection against septic death. in mice deficient in SR-BI were significantly more to CLP-induced septic death. CLP induced fatality in SR-BI-null mice and in wild type at fatality in SR-BI-null mice and in wild type at and 100% fatality in SR-BI-null mice but only 21% fatality in wild type at protection against CLP-induced by Compared with wild type controls, SR-BI-null mice had a increase in levels 20 h following CLP treatment. findings that SR-BI is a critical survival factor in sepsis. A response that high levels of inflammatory cytokines the of the against uncontrolled production of cytokines is a major cause of septic death J. Nature. 2002; PubMed Scopus Google Scholar). To understand why SR-BI-null mice are to septic we inflammatory cytokine production in SR-BI-null and wild type littermates. We the mice with CLP for and 20 h and the cytokine in SR-BI-null and wild type mice exhibited inflammatory responses during sepsis. type mice exhibited a response with a and of and in the early stage of sepsis with in and levels by 20 SR-BI-null mice exhibited an aberrant of inflammatory cytokine generation during sepsis. h after CLP and levels in SR-BI-null the were significantly than that of wild type a delayed response in SR-BI-null mice. in to the in cytokine levels in wild type mice 20 h after CLP the and levels to increase in SR-BI-null a and uncontrolled cytokine generation in the stage of sepsis in the absence of SR-BI a and to is key in response during sepsis 1999; PubMed Scopus Google Scholar). nitric-oxide synthase expression in macrophages is induced to a high of which is used to and 1999; PubMed Scopus Google Scholar). is and cause oxidative cell damage Am. J. 1996; 271: PubMed Google Scholar). We and levels to SR-BI production in sepsis. in SR-BI-null mice exhibited an aberrant of generation during sepsis. In to an increase in generation in the early stage of sepsis in wild type the generation in SR-BI-null mice significantly than that of wild type controls, a delayed generation in SR-BI-null mice. the in levels in the stage of sepsis in wild type the levels in SR-BI-null mice the at h and high at 20 a generation in the stage of sepsis in the absence of SR-BI is highly expressed in It mediates the intracellular uptake of cholesterol from HDL in providing for M. 1999; PubMed Scopus Google Scholar). A by L. A. J. Clin. Investig. PubMed Scopus Google that SR-BI-null mice have a in generation in and of to SR-BI-null mice the mice from that production to its protection against animal death. We elucidated the effect of SR-BI on generation during sepsis by CLP induced a increase in generation in wild type mice h following CLP but mice deficient in SR-BI to during sepsis that SR-BI is for production during sepsis. To this production to its protection against septic we in to SR-BI-null mice h to CLP following the by L. A. J. Clin. Investig. PubMed Scopus Google Scholar). in to protection against animal death by L. A. J. Clin. Investig. PubMed Scopus Google Scholar), to SR-BI-null mice from CLP-induced septic death The that SR-BI is for production during sepsis, but this production is not for protection against septic death. We for an for SR-BI protection against septic death. that SR-BI is expressed in macrophages and that macrophages are one of the major of cells that inflammatory cytokines during sepsis Am. J. 2002; PubMed Scopus (429) Google Scholar, T. M. R.G. 2001; PubMed Scopus Google Scholar), we SR-BI cytokine production using We the macrophages with LPS and and type and SR-BI-null macrophages exhibited inflammatory responses to LPS and wild type macrophages, production its by and production its by for SR-BI-null macrophages, the and levels to and cytokine levels of wild type macrophages by 20 uncontrolled and generation in macrophages deficient in We also the macrophages with of LPS. In the presence of levels of LPS induced the generation of and in an LPS and the presence of SR-BI suppressed the generation of and and We used SR-BI transgenic mice to expression of SR-BI in macrophages to protection against septic death. In using this an is our to the effect of SR-BI on modulating inflammatory response in macrophages from its on NO-induced and regulating generation. To the we used the early studies that this SR-BI its and (21Li X.A. Guo L. Dressman J.L. Asmis R. Smart E.J. J. Biol. Chem. 2005; 280: 19087-19096Abstract Full Text Full Text PDF PubMed Scopus (59) Google Scholar, X.A. Guo L. Asmis R. Nikolova-Karakashian M. Smart E.J. Circ. Res. 2006; 98: e60-65Crossref PubMed Scopus (24) Google Scholar). also that this its cholesterol uptake L. G. A. and the SR-BI is a to the of the macrophage SR-BI to sepsis. We the transgenic mice and the mice with SR-BI-null mice to transgenic mice in an SR-BI-null a and We cells from the transgenic and and the expression of in macrophages we the effect of on inflammatory cytokine generation using the expression of the SR-BI in macrophages significantly suppressed the generation of or with SR-BI-null mice and we the transgenic mice with in and transgenic mice not a in plasma levels during sepsis but were significantly more resistant to CLP-induced septic death with SR-BI-null mice. is a key that mediates inflammatory response in macrophages during sepsis A. Van C. M. C. M. P. B. B. Science. PubMed Scopus Google Scholar, C. 2002; PubMed Scopus Google Scholar). LPS from activates to a leading to the of which activates the of inflammatory and nitric-oxide synthase C. 2002; PubMed Scopus Google Scholar, Mol. 2007; Google Scholar). We SR-BI inflammatory response using a cell The cell and the NF-κB it is a to We cells that SR-BI or in LPS induced of NF-κB in an LPS Importantly, the presence of SR-BI significantly suppressed NF-κB that SR-BI TLR4-mediated inflammatory We also cells to wild type the SR-BI suppressed TLR4-mediated NF-κB especially HDL, have to LPS and LPS A.R. J. Clin. Investig. PubMed Scopus Google Scholar, A.R. J. Clin. Investig. PubMed Scopus Google Scholar). an HDL receptor, SR-BI plays an role in regulating plasma lipoprotein Mice deficient in SR-BI have a 2-fold increase in plasma cholesterol levels and HDL with wild type controls (10Rigotti A. Trigatti B.L. Penman M. Rayburn H. Herz J. Krieger M. Proc. Natl. Acad. Sci. U.S.A. 1997; 94: 12610-12615Crossref PubMed Scopus (761) Google Scholar). a that in lipoprotein levels in SR-BI-null mice to to sepsis. To the role of SR-BI in lipoprotein metabolism during sepsis, we cholesterol levels and lipoprotein 20 h after CLP treatment. CLP plasma cholesterol levels in SR-BI-null and wild type but the were not and The lipoprotein were by with protein reported SR-BI-null mice had HDL with wild type CLP not significantly lipoprotein in SR-BI-null or wild type mice Using a L. A. J. Clin. Investig. PubMed Scopus Google that plasma from wild type and SR-BI-null mice had the to and that in in SR-BI-null mice not the of to LPS. in studies that SR-BI the uptake of R. Z. M. F. A. G. Proc. Natl. Acad. Sci. U.S.A. 2006; PubMed Scopus Google Scholar, Z. G. J. Biol. Chem. 2003; 278: Full Text Full Text PDF PubMed Scopus Google Scholar), that SR-BI a role in clearance in sepsis. We and the using in in the SR-BI-null and wild type mice 20 h after CLP of of cells in the the major of macrophages in the To SR-BI uptake by macrophages during sepsis, we from the and with using type mice to have more in the with SR-BI-null mice 20 h after CLP but the is not of of SR-BI to LPS and LPS intracellular uptake in R. Z. M. F. A. G. Proc. Natl. Acad. Sci. U.S.A. 2006; PubMed Scopus Google Scholar, Z. G. J. Biol. Chem. 2003; 278: Full Text Full Text PDF PubMed Scopus Google Scholar), which the that SR-BI LPS clearance during sepsis. We plasma LPS levels in mice. SR-BI-null mice had a significantly higher plasma LPS levels than wild type controls 20 h following CLP that SR-BI is for LPS clearance during sepsis We also with wild type controls, SR-BI-null mice had lower plasma LPS levels in the early stage of sepsis, that SR-BI is for LPS recruitment from to that SR-BI is a critical survival factor of sepsis in mice. In to protection by production in animal not protection against CLP-induced septic animal death. studies reveal that SR-BI protects against septic death through its role in modulating inflammatory responses in macrophages and facilitating LPS recruitment and clearance. SR-BI is for generation in and L. A. J. Clin. Investig. PubMed Scopus Google Scholar, M. M. R. Hildebrand R.B. Kruijt J.K. Van Eck M. Van Berkel T.J. J. Res. Full Text Full Text PDF PubMed Scopus Google Scholar). L. A. J. Clin. Investig. PubMed Scopus Google reported that of to SR-BI-null mice mice from death from 100% to that production plays a major protective role in In this study, we the role of SR-BI in generation during sepsis and its to septic death. We demonstrate that SR-BI is for production during sepsis. of to SR-BI-null mice from CLP-induced animal which is from the efficient protection of against death. We that the of on and sepsis are a of the responses involved in and sepsis. an of LPS induces of inflammatory leading to damage and death. it inflammatory response and animal death L. A. J. Clin. Investig. PubMed Scopus Google Scholar). sepsis, LPS that the to inflammatory but the inflammatory cytokines have and The inflammatory cytokines cause but are also for against inflammatory cytokine generation in sepsis, especially in its early this the system, in uncontrolled and septic death. We for an for the protective role of SR-BI in sepsis. the that SR-BI is expressed in macrophages and that the macrophage is one of the major that response, we of to our that SR-BI protects against septic death through its role in modulating response of we expression of SR-BI in macrophages inflammatory response using Macrophages deficient in SR-BI significantly higher levels of and by 20 h of LPS with wild type macrophages, a and uncontrolled inflammatory response in the absence of we expression of SR-BI in macrophages to protection against septic death. A of used to the role of SR-BI in macrophages in used to the of macrophage SR-BI to the development of atherosclerosis (23Covey S.D. Krieger M. Wang W. Penman M. Trigatti B.L. Arterioscler. Thromb. Vasc. Biol. 2003; 23: 1589-1594Crossref PubMed Scopus (195) Google Scholar, 24Zhang W. Yancey P.G. Su Y.R. Babaev V.R. Zhang Y. Fazio S. Linton M.F. Circulation. 2003; 108: 2258-2263Crossref PubMed Scopus (174) Google Scholar, 25Van Eck M. Bos I.S. Hildebrand R.B. Van Rij B.T. Van Berkel T.J. Am. J. Pathol. 2004; 165: 785-794Abstract Full Text Full Text PDF PubMed Scopus (149) Google In this study, we transgenic mice the We of of this animal cholesterol uptake that we the of generation to sepsis. SR-BI of apoptosis and protection against (21Li X.A. Guo L. Dressman J.L. Asmis R. Smart E.J. J. Biol. Chem. 2005; 280: 19087-19096Abstract Full Text Full Text PDF PubMed Scopus (59) Google Scholar, X.A. Guo L. Asmis R. Nikolova-Karakashian M. Smart E.J. Circ. Res. 2006; 98: e60-65Crossref PubMed Scopus (24) Google Scholar), which to its protection against septic death. or that we also We the used in that the of septic M. R. M. L. M. 2002; 90: PubMed Scopus Google Scholar). this animal model, we that SR-BI is of modulating inflammatory response in macrophages importantly, provides protection against CLP-induced septic death. we SR-BI inflammatory response by modulating using a cell The cell and its and The cell also a NF-κB which it a to TLR4-mediated inflammatory We that LPS in NF-κB and expression of SR-BI significantly suppressed NF-κB activation. and NF-κB are molecules that inflammatory cytokine production in macrophages, we that SR-BI the inflammatory response SR-BI LPS uptake in Z. G. J. Biol. Chem. 2003; 278: Full Text Full Text PDF PubMed Scopus Google Scholar). of it that mice deficient in SR-BI have delayed LPS clearance from L. A. J. Clin. Investig. PubMed Scopus Google Scholar). In this study, we plasma LPS levels to the effect of SR-BI on LPS metabolism during sepsis. SR-BI-null mice had significantly higher plasma LPS levels than the wild type controls 20 h following CLP that SR-BI is for LPS clearance during sepsis. We also an that SR-BI-null mice had lower plasma LPS levels in the early stage of sepsis with wild type controls, that SR-BI is for LPS recruitment from to The in LPS recruitment an to why SR-BI-null mice had delayed inflammatory responses during the early stage of sepsis. It is that the in cytokine production and in cytokine production by SR-BI-null mice with CLP are with but this is not studies are to the of this delayed inflammatory response to septic death. SR-BI to protection against inflammatory diseases through its role in modulating inflammatory response in Using early studies have that expression of SR-BI in macrophages protects against the development of atherosclerosis (23Covey S.D. Krieger M. Wang W. Penman M. Trigatti B.L. Arterioscler. Thromb. Vasc. Biol. 2003; 23: 1589-1594Crossref PubMed Scopus (195) Google Scholar, 24Zhang W. Yancey P.G. Su Y.R. Babaev V.R. Zhang Y. Fazio S. Linton M.F. Circulation. 2003; 108: 2258-2263Crossref PubMed Scopus (174) Google Scholar, 25Van Eck M. Bos I.S. Hildebrand R.B. Van Rij B.T. Van Berkel T.J. Am. J. Pathol. 2004; 165: 785-794Abstract Full Text Full Text PDF PubMed Scopus (149) Google Scholar). expression of SR-BI in macrophages not plasma lipoprotein or cholesterol efflux in macrophages, that the macrophage SR-BI exerts its protective a of its role in regulating cholesterol more studies are to the mechanisms underlying macrophage SR-BI protection against atherosclerosis, our findings that SR-BI TLR4-mediated inflammatory response in macrophages provides a for the protection of SR-BI against atherosclerosis M.H. Zhang W. J. S. M. Proc. Natl. Acad. Sci. U.S.A. 2004; 101: PubMed Scopus Google Scholar). In we demonstrate that SR-BI is a critical protective modulator in sepsis. We reveal that SR-BI protects against septic death through its role in modulating response in macrophages and through its role in of LPS from Importantly, by using a transgenic model, we that of the SR-BI provides protection against septic death. findings a for the of sepsis. We the of the for and
36
Defective LPS Signaling in C3H/HeJ and C57BL/10ScCr Mice: Mutations in <i>Tlr4</i> Gene
Alexander Poltorak, Xiaolong He, Irina Smirnova et al. · Science · 1998 · 7.6K citations
Identification of Scavenger Receptor SR-BI as a High Density Lipoprotein Receptor
Susan Acton, Attilio Rigotti, Katherine T. Landschulz et al. · Science · 1996 · 2.3K citations
Kathrin S. Michelsen, Michelle Wong, Prediman K. Shah et al. · Proceedings of the National Academy of Sciences · 2004 · 1K citations · Full text